ClinicalTrialsFinder

Basal Cell Carcinoma (BCC) Clinical Trials in Heidelberg

1 recruitingHeidelberg, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 2

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

First-line TreatmentBasal Cell Carcinoma (BCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest34 enrolled7 locationsNCT06981325